8-K
Current Report
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-24-040955
Director nominations · Other events
- Item 5.08 Shareholder director nominations
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading ea020556601-8k_cadrenal.htm…